Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
157.3 USD | -0.43% | -2.04% | +63.27% |
06-26 | Monetary policy is getting even more confusing | |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.27% | 14.93B | |
+17.02% | 122B | |
+19.65% | 113B | |
+18.84% | 26.49B | |
-23.32% | 19.4B | |
-18.79% | 16.24B | |
-20.70% | 15.4B | |
-45.95% | 15.15B | |
+3.97% | 13.52B | |
+116.07% | 10.79B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. - Special Call